Guijarro-Eguinoa, J.; Arjona-Hernandez, S.; Stewart, S.; Pernia, O.; Arias, P.; Losantos-GarcÃa, I.; Rubio, T.; Burdiel, M.; Rodriguez-Antolin, C.; Cruz-Castellanos, P.;
et al. Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy. Int. J. Mol. Sci. 2023, 24, 9843.
https://doi.org/10.3390/ijms24129843
AMA Style
Guijarro-Eguinoa J, Arjona-Hernandez S, Stewart S, Pernia O, Arias P, Losantos-GarcÃa I, Rubio T, Burdiel M, Rodriguez-Antolin C, Cruz-Castellanos P,
et al. Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy. International Journal of Molecular Sciences. 2023; 24(12):9843.
https://doi.org/10.3390/ijms24129843
Chicago/Turabian Style
Guijarro-Eguinoa, Javier, Sara Arjona-Hernandez, Stefan Stewart, Olga Pernia, Pedro Arias, Itsaso Losantos-GarcÃa, Tania Rubio, Miranda Burdiel, Carlos Rodriguez-Antolin, Patricia Cruz-Castellanos,
and et al. 2023. "Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy" International Journal of Molecular Sciences 24, no. 12: 9843.
https://doi.org/10.3390/ijms24129843
APA Style
Guijarro-Eguinoa, J., Arjona-Hernandez, S., Stewart, S., Pernia, O., Arias, P., Losantos-GarcÃa, I., Rubio, T., Burdiel, M., Rodriguez-Antolin, C., Cruz-Castellanos, P., Higuera, O., Borobia, A. M., Rodriguez-Novoa, S., de Castro-Carpeño, J., Ibanez de Caceres, I., & Rosas-Alonso, R.
(2023). Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy. International Journal of Molecular Sciences, 24(12), 9843.
https://doi.org/10.3390/ijms24129843
